Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis.
about
The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic managementCystic fibrosis transmembrane conductance regulator regulates epithelial cell response to Aspergillus and resultant pulmonary inflammationCharacteristics of pathogenic fungi and antifungal therapy in cystic fibrosis.Characterization and quantification of the fungal microbiome in serial samples from individuals with cystic fibrosisRichness and diversity of mammalian fungal communities shape innate and adaptive immunity in health and disease.Pseudomonas aeruginosa manipulates redox and iron homeostasis of its microbiota partner Aspergillus fumigatus via phenazines.The Black Yeast Exophiala dermatitidis and Other Selected Opportunistic Human Fungal Pathogens Spread from Dishwashers to KitchensRoutine processing procedures for isolating filamentous fungi from respiratory sputum samples may underestimate fungal prevalence.Prospective multicenter German study on pulmonary colonization with Scedosporium /Lomentospora species in cystic fibrosis: Epidemiology and new association factorsIsolation of filamentous fungi from sputum in asthma is associated with reduced post-bronchodilator FEV1.Pathogenesis of Fungal Infections in Cystic Fibrosis.Update in cystic fibrosis 2010.Impact of Aspergillus fumigatus in allergic airway diseasesFungal culture and sensitisation in asthma, cystic fibrosis and chronic obstructive pulmonary disorder: what does it tell us?Proteomics of hosts and pathogens in cystic fibrosis.Toward the Standardization of Mycological Examination of Sputum Samples in Cystic Fibrosis: Results from a French Multicenter Prospective Study.Aspergillus Biofilms in Human Disease.Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.Th17/Treg imbalance in murine cystic fibrosis is linked to indoleamine 2,3-dioxygenase deficiency but corrected by kynurenines.Fungal Pathogens in CF Airways: Leave or Treat?Pseudomonas aeruginosa Inhibits the Growth of Scedosporium and Lomentospora In Vitro.Use of Selective Fungal Culture Media Increases Rates of Detection of Fungi in the Respiratory Tract of Cystic Fibrosis Patients.Association of chronic Candida albicans respiratory infection with a more severe lung disease in patients with cystic fibrosis.Inhaled corticosteroids and Aspergillus fumigatus isolation in cystic fibrosis.Hypoxia promotes danger-mediated inflammation via receptor for advanced glycation end products in cystic fibrosis.Outpatient treatment of Pseudomonas aeruginosa bronchial colonization with long-term inhaled colistin, tobramycin, or both in adults without cystic fibrosis.Fungi in Bronchiectasis: A Concise Review.Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory.A rapid microplate method for the proliferation assay of fungi and the antifungal susceptibility testing using the colorimetric microbial viability assay.Aspergillus fumigatus chronic colonization and lung function decline in cystic fibrosis may have a two-way relationship.Successful lung transplant in a child with cystic fibrosis and persistent Blastobotrys rhaffinosifermentans infection.Commensal Fungi in Health and Disease.The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis.Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis.Characteristics and consequences of airway colonization by filamentous fungi in 201 adult patients with cystic fibrosis in France
P2860
Q28730299-7FE34E02-9C36-42AF-AEE8-2E0E6F5FE078Q33738695-E4618233-B23A-4BD6-A4FC-69C7C8288E12Q34130445-EA630B89-2CDA-44B8-8FE5-93E347400F46Q34536205-5CC2B2E2-66CF-4EC0-98C5-21468B2390F1Q35278095-E25B12A3-C6D9-4846-83AE-22C4FF06290EQ35558423-D0D9CDD2-82C7-4CAE-A2E4-A45EAA6F04D3Q35920933-1A3644BD-8A63-4E7B-83CC-826EFDC0420DQ36102778-887197D4-4032-483C-B5B4-EB5652D29114Q36274268-8DEE3151-E82D-4188-AA68-5E1600554CB9Q36431204-B19663E5-C055-4B28-9C2F-DBCDEA89BE7CQ37500602-8B8192C3-003C-4104-BFF9-F40846E10DDDQ37892766-B508A00E-A9AC-4B8E-B8FC-0D32850214D1Q37992771-9A36A4A0-9C3E-4EE7-BA1B-BC6A6765B9E1Q38242666-B62FD6FA-03A3-4924-91D7-FAF5E551A259Q38270707-41D8B353-B79F-4125-A22F-79850108558BQ38651242-FB34A238-78B1-4FEA-A49A-6429BE8E4A4BQ38857862-05123C94-F42F-4C3D-AA3E-B80BAF2B69CDQ39282119-4FC2F0DF-67AC-4230-BB1C-20298450EC68Q39488014-E60B560D-3DAF-434C-B5CD-214CEF30854FQ40108783-35D34F6F-0692-499D-BBC3-BF2BF17A7674Q40209634-DD56EC68-23C8-4BFE-96C3-9C39326F83C8Q40366526-8C5CE7A8-38F0-41B6-8C0A-EF49BA03B4D2Q40525694-E59AB67D-A4CE-452B-8B52-5FF3059AD47EQ42204693-893F5C62-1D7B-498D-A048-AD298618AF4CQ44909879-302B29A8-BAA9-411E-BB10-EF4C9B0FE38CQ46140564-A1F148F9-1DF6-4EB6-918B-CAE3A55FD5B4Q47558222-8FDCDAF9-5D5A-4BA6-B771-CE83D2C55C96Q47814293-0F347704-D568-44F6-94D5-C1ECD9D096D7Q50700721-8B164B4B-13C9-4450-8812-0F70CFE0D4E4Q51599682-A5765E9A-874E-4BFB-8DBD-949607D1B771Q51716959-04F6267A-E4D3-4CAE-BFE0-D6587D86500FQ52759357-D6E23582-EF17-440C-B8B0-9DA088D6679AQ54296123-535EFC4A-45D4-438F-95C8-13B20B5FA869Q55433449-DC55EAFF-DF94-4FC3-9E8C-19F454910E33Q58810995-11B6A6CA-A71F-4774-93E3-7FC466BD9AD2
P2860
Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Prevalence and risk factors fo ...... ividuals with cystic fibrosis.
@en
Prevalence and risk factors fo ...... ividuals with cystic fibrosis.
@nl
type
label
Prevalence and risk factors fo ...... ividuals with cystic fibrosis.
@en
Prevalence and risk factors fo ...... ividuals with cystic fibrosis.
@nl
prefLabel
Prevalence and risk factors fo ...... ividuals with cystic fibrosis.
@en
Prevalence and risk factors fo ...... ividuals with cystic fibrosis.
@nl
P2093
P2860
P1476
Prevalence and risk factors fo ...... dividuals with cystic fibrosis
@en
P2093
Christopher R Sudfeld
Karen C Carroll
William G Merz
P2860
P304
P356
10.1016/J.JCF.2009.11.010
P577
2009-12-31T00:00:00Z